Special Issue "Natural Anti-Biofilm Agents"
Deadline for manuscript submissions: 20 March 2024 | Viewed by 4300
Interests: antimicrobial resistance; new antimicrobial compounds; biofilm; biofilm-related infections; anti-biofilm; nanomaterials; mycology; advanced diagnostic
Interests: clinical mycology; antimicrobial resistance; antimicrobial compounds; biofilm-related infections; anti-biofilm nanomaterials
Biofilm is a complex structure composed of an organized aggregation of single or multiple microbial species, which is surrounded by an extra-cellular polymeric substance and attached to biotic or abiotic surfaces. Cells in biofilm are more resistant to environmental stresses such as nutrient depletion. Biofilm can be formed in the human body or medical devices, causing difficult-to-treat infections with a high risk of recalcitrant episodes. This is due to the different properties of the biofilm: evasion from the immune system, low metabolic rate, tolerance, and resistance to antimicrobial therapies. Research in recent years has aimed to identify new compounds with anti-biofilm activity; particularly, the use of “green” molecules, such as phytochemicals, antimicrobial peptides, green synthetized nanoparticles and nanomaterials, are of great interest. The scope of this Special Issue is to publish papers about the anti-biofilm activity of green compounds and their possible application in medicine, the food industry and livestock. Submitted manuscripts should include in vitro and/or in vivo studies of phytochemicals (phenolics, essential oils, terpenoids, lectins, alkaloids, polypeptides and polyacetylenes); antimicrobial peptides; naturally synthetized nanoparticles (silver nanoparticles, cooper, titanium, etc.); and green synthetized nanomaterials that are able to inhibit a microorganism’s adhesion and biofilm formation, along with their mechanism of action and/or possible application.
Dr. Margherita Cacaci
Dr. Riccardo Torelli
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- green anti-biofilm antimicrobial peptides
- new green nanomaterials for medical devices or animal food contact surfaces